Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin in infants with Prader-Willi syndrome
2010-022370-14Phase 2
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxytocin in Prader-Willi syndrome (PWS), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: Blood pressure measurement, Heart rate measurement and 2 more.
02
Drugs
oxytocin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on 2010-022370-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022370-14.